Sonnet BioTherapeutics Holdings, Inc. (SONN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 3.1 |
| Open | 3.16 |
| Day High | 3.23 |
| Day Low | 1.26 |
| 52-Week High | 19.3 |
| 52-Week Low | 1.08 |
| Volume | 10.43M |
| Average Volume | 1.11M |
| Market Cap | 8.43M |
| PE | -0.18 |
| EPS | -6.82 |
| Moving Average 50 Days | 4.58 |
| Moving Average 200 Days | 3.04 |
| Change | -1.84 |
Data not available
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
GlobeNewswire Inc.
Dec 02, 2025 9:30 PM GMT
Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Under the Ticker “PURR”NEW YORK and PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hyperliquid Strategies Inc (“HSI” or the “Company”) and Sonnet B
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
GlobeNewswire Inc.
Dec 02, 2025 2:17 PM GMT
PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that its stockholders approved, among other things, the proposed business combination with Hyperliq
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
GlobeNewswire Inc.
Nov 18, 2025 2:00 PM GMT
PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has adjourned its special meeting of stockholders (the “Special Meeting”) in order to provi